[{"Assets_0_Q3_USD":"435235000.0","CIK":"1737287","CommonStockDividendsPerShareDeclared_3_Q3_USD":"0.0","CommonStockSharesConverted_0_Q3_shares":"31270573.0","CommonStockSharesOutstanding_0_Q3_shares":"31270573.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-10.71","EarningsPerShareBasic_3_Q3_USD":"-16.38","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-23172000.0","NetIncomeLoss_1_Q3_USD":"-43497000.0","NetIncomeLoss_3_Q3_USD":"-180996000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_3_Q3_USD":"-180996000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"-168443000.0","Ticker":"ALLO","filed":"20181121","footnote":null,"form":"10-Q","fp":"Q3","fy":"2018.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20180930","qtrs":"0","uom":"USD"}]